p70 S6 kinase (p70S6K) is an important regulator of cell proliferation. Its activation by growth factor requires phosphorylation by various inputs on multiple sites, Data accumulated thus far support a model whereby p70S6K activation requires sequential phosphorylations at proline-directed residues in the putative autoinhibitory pseudosubstrate domain, as well as threonine 389. Threonine 229, a site in the catalytic loop is phosphorylated by phosphoinositide-dependent kinase 1 (PDK-1), Experimental evidence suggests that p70S6K activation requires a phosphoinositide 3-kinase (PI3-K)-dependent signal(s), However, the intermediates between PI3-K and p70S6K remain unclear. Here,we have identified PI3-K-regulated atypical protein kinase C (PKC) isoform PKC zeta as an upstream regulator of p70S6K. In coexpression experiments, we found that a kinase-inactive PKC zeta mutant antagonized activation of p70S6K by epidermal growth factor, PDK-1, and activated Cdc42 and PI3-K. While overexpression of a constitutively active PKC zeta mutant (myristoylated PKC zeta [myr-PKC zeta]) only modestly activated p70S6K, this mutant cooperated with PDK-1 activation of p70S6K, PDK-1-induced activation of a C-terminal truncation mutant of p70S6K was also enhanced by myr-PKC zeta. Moreover, we have found that p70S6K can associate with both PDK-1 and PKC zeta in vivo in a growth factor-independent manner, while PDK-1 and PKC zeta can also associate with each other, suggesting the existence of a multimeric PI3-K signalling complex. This work provides evidence for a link between a phorbol ester-insensitive PKC isoform and p70S6K. The existence of a PI3-K-dependent signalling complex may enable efficient activation of p70S6K in cells.